Bioxima, a biotechnology company, is going to invest over PLN 14 million in the Lublin subzone of the Special Economic Zone Euro-Park Mielec. The company will build there its new factory and the R&D centre. More importantly Bioxima is already present in the zone – it has its head office and a factory here. This will therefore be next Bioxima’s investment in the Lublin zone.
BioMaxima is a Polish biotechnology company that manufactures laboratory diagnostic products. Its new factory will produce microbiological tests, diagnostic fluids, biochemical analysers, disks and tablets for determination of drug resistance .
In turn R&D centre is planned to be used for works on development of new innovative tests for determination of drug resistance, rapid diagnostic tests and innovative biochemical analysers.
Do you know that …?
The biotechnology industry is one the twelve priority industries supported by the Polish government.